Search

Fifteen scientists in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern received more than $17 million in research funds in the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).

Scientists with UT Southwestern’s Peter O’Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication.

Four out of five Americans 65 and older want to stay in their homes as they age, according to a recent Associated Press poll. But deciding how long an elderly relative should live alone and when they should move to an environment with more support – such as assisted living or a nursing home – can be

Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease.

Dr. Warner took on a larger role in launching a program that brought together EMS and hospitals to speed treatment for people in Dallas who experience a severe type of heart attack known as a STEMI.

UT Southwestern researchers have identified a four-protein complex that appears to play a key role in generating ribosomes – organelles that serve as protein factories for cells – as well as a surprising part in neurodevelopmental disorders.

The National Institutes of Health (NIH) and the National Institute on Aging recently approved funding for a 2022 study by the Institute for Exercise and Environmental Medicine (IEEM).

The March 21 decision by NCCN to include the Simmons Cancer Center among its members recognizes Simmons Cancer Center’s elite status and will deepen its collaboration with national peers at the highest levels.

A healthy diet, regular exercise, and sufficient sleep can help prevent the onset of diabetes, a condition affecting more than 37 million Americans, according to Bethany Agusala, M.D., Assistant Professor of Internal Medicine at UT Southwestern.

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) with KRAS mutations, a clinical trial led by UT Southwestern Harold C. Simmons Comprehensive Cancer Center researchers showed.